Nov 2018

WORLD-FIRST MEDICINAL CANNABIS TRIAL TO TREAT BRAIN CANCER

A new world-first trial will examine whether oral medicinal cannabis can affect tumour growth in patients with glioma, a common type of brain cancer. As well as supporting the standard treatment for a brain tumour, researchers also hope that medicinal cannabis will have a positive impact on patient’s quality of life. Read the article here.

Our CEO and founder, Matt Cantelo has met with the business editor at The Sydney Morning Herald to discuss the future of medicinal cannabis in Australia, ANTG’s export plans and company’s current investments into research.

READ MORE >

A story of six year old Cooper who has been diagnosed with Epilepsy two years ago. After trying a range of traditional medications over the years with very little success, Cooper’s parents decided to start on medicinal product to help him with seizures that have eventually stopped.

READ MORE >

To help Australian patients easily access the best quality medicinal cannabis, Greg Hunt, the health minister has launched Medicinal Cannabis Industry Australia. The role of this newly created industry body will be to ensure that medicinal cannabis products achieve the highest standards to meet patients’ individual needs.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >